Cartesian Therapeutics's market cap is currently ―. The company's EPS TTM is $-9.71; its P/E ratio is -1.93; Cartesian Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 8.27M	$ 6.55M	$ 5.25M	$ 5.94M	$ 16.80M
Gross Profit	$ 8.27M	$ 6.55M	$ 5.25M	$ 5.94M	$ 16.80M
EBIT	$ -196.66M	$ -7.73M	$ -10.63M	$ -20.86M	$ 5.27M
EBITDA	$ -195.91M	-	$ -10.03M	$ -20.31M	$ 5.56M
Net Income Common Stockholders	$ -177.66M	$ -9.00M	$ -11.39M	$ -21.66M	$ 5.89M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 76.91M	$ 79.60M	$ 112.03M	$ 125.92M	$ 134.60M
Total Assets	$ 305.05M	$ 106.03M	$ 139.51M	$ 155.69M	$ 165.89M
Total Debt	$ 10.96M	$ 10.48M	$ 34.91M	$ 37.73M	$ 37.92M
Net Debt	$ -65.96M	$ -69.12M	$ -77.11M	$ -88.19M	$ -96.68M
Total Liabilities	$ 444.68M	$ 45.70M	$ 57.18M	$ 81.11M	$ 515.92M
Stockholders Equity	$ -440.18M	$ 60.33M	$ 82.33M	$ 74.58M	$ 463.00M
Cash Flow	-
Free Cash Flow	$ -23.35M	-	$ -9.91M	$ -8.89M	$ -12.17M
Operating Cash Flow	$ -23.29M	$ -9.21M	$ -9.89M	$ -8.77M	$ -11.96M
Investing Cash Flow	$ 6.50M	-	$ -12.00K	$ 28.12M	$ 5.49M
Financing Cash Flow	$ 14.08M	$ -24.79M	$ -2.59M	$ 149.00K	$ 2.23M

Currency in USD

Cartesian Therapeutics Earnings and Revenue History

Income Statement >

Cartesian Therapeutics Debt to Assets

Balance Sheet >

Cartesian Therapeutics Cash Flow

Cash Flow >

Cartesian Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing